TABLE 1.
The docking results of ellagic acid and urolithins with key targets.
| Drug | Gene name | PDB ID | Score |
| UA | AKT1 | 6ccy | 6.168 |
| UB | AKT1 | 6ccy | 6.367 |
| UM5 | AKT1 | 6ccy | 4.943 |
| UM6 | AKT1 | 6ccy | 3.744 |
| EA | AKT1 | 6ccy | 6.170 |
| UA | IGF1R | 2oj9 | 6.844 |
| UB | IGF1R | 2oj9 | 6.285 |
| UM5 | IGF1R | 2oj9 | 8.594 |
| UM6 | IGF1R | 2oj9 | 5.678 |
| EA | IGF1R | 2oj9 | 5.837 |
| UA | NFKB1 | 1ikn | 5.241 |
| UB | NFKB1 | 1ikn | 5.084 |
| UM5 | NFKB1 | 1ikn | 3.618 |
| UM6 | NFKB1 | 1ikn | 4.203 |
| EA | NFKB1 | 1ikn | 4.407 |
| UA | EGFR | 4i24 | 5.525 |
| UB | EGFR | 4i24 | 5.690 |
| UM5 | EGFR | 4i24 | 4.685 |
| UM6 | EGFR | 4i24 | 3.891 |
| EA | EGFR | 4i24 | 5.929 |
| UA | MAPK14 | 5wjj | 6.726 |
| UB | MAPK14 | 5wjj | 6.255 |
| UM5 | MAPK14 | 5wjj | 8.258 |
| UM6 | MAPK14 | 5wjj | 7.740 |
| EA | MAPK14 | 5wjj | 7.547 |